Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test
- 31 January 2003
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 17 (3) , 597-604
Abstract
It is generally accepted that the phospholipase‐A2‐cyclooxygenase‐prostanoids‐cascade mediates spinal sensitization and hyperalgesia. However, some observations are not in line with this hypothesis. ...Keywords
This publication has 39 references indexed in Scilit:
- Small part of cannabis puzzle solved by animal studiesThe Lancet, 2001
- Chronic intrathecal cannulation enhances nociceptive responses in ratsBrazilian Journal of Medical and Biological Research, 2000
- Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulatorsLife Sciences, 1999
- Use and Benefits of Nonsteroidal Anti-inflammatory DrugsThe American Journal of Medicine, 1998
- Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonistBritish Journal of Pharmacology, 1997
- Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidaseBiochemical Pharmacology, 1997
- Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamateInflammation Research, 1996
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibitionCellular and Molecular Life Sciences, 1991
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977